Mandos LLC: Clinical Trials

3 trials sponsored by Mandos LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 33Terminated 2, Completed 1

Follow Mandos LLC: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
VTS-270 - Niemann-Pick Disease, Type C
Phase 2 / Phase 3TerminatedMandos LLC22019-12-022023-12-26
Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
Adrabetadex - Niemann-Pick Disease, Type C
Phase 2 / Phase 3TerminatedMandos LLC662015-12-232023-08-29
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C
Phase 2 / Phase 3CompletedMandos LLC562015-10-012023-02-22

Conditions studied

Niemann-Pick Disease, Type C (3)  ·  Cognitive Dysfunction (2)  ·  Deglutition Disorders (2)  ·  Disease (2)  ·  Mobility Limitation (2)

Interventions

2-Hydroxypropyl-beta-cyclodextrin (3)  ·  Cyclodextrins (3)

Countries

Australia (2)  ·  France (2)  ·  Germany (2)  ·  New Zealand (2)  ·  Singapore (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Costa Rica (1)  ·  Spain (1)  ·  Switzerland (1)

Results publications

PMID 40525490

NIH funding

2015 (2)